Late-onset medullary carcinoma of the thyroid: Need for genetic testing and prophylactic thyroidectomy in adult family members

Laryngoscope

Volumn 116, Issue 9, 2006, Pages 1704-1707

  Shaha, Ashok R ^a   Cohen, Tzeela ^a   Ghossein, Ronald ^a   Tuttle, R Michael ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

C cell hyperplasia; Medullary thyroid cancer; RET proto oncogene; Thyroid cancer

Indexed keywords

PROTEIN RET;

ADULT; AGED; ANAMNESIS; ARTICLE; CALCITONIN BLOOD LEVEL; CASE REPORT; CELL HYPERPLASIA; FAMILY ASSESSMENT; FEMALE; GENE MUTATION; GENE TRANSFER; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MEDULLARY CARCINOMA; PRIORITY JOURNAL; PROPHYLAXIS; RADIODIAGNOSIS; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID MASS; THYROIDECTOMY; THYROIDITIS;

ADULT; AGED; CARCINOMA, MEDULLARY; FEMALE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33748523134     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000233509.83679.ee     Document Type: Article

References (16)

1. Clayman GL, El-Baradie TS. Medullary thyroid cancer. Otolaryngol Clin North Am 2003;36:91-105.
2. Hundahl SA, Felming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 1998;83: 2638-2648.
3. Phay JE, Moley JF, Lairmore TC. Multiple endocrine neoplasias. Semin Surg Oncol 2000;18:324-332.
4. Randolph GW, Maniar D. Medullary carcinoma of the thyroid. Cancer Control 2000;7:253-261.
5. Wells SA Jr, Baylin SB, Leight GS, et al. The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg 1982;195:595-599.
6. Wells SA, Chi DD, Toshima K, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-247.
7. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996;276:1575-1579.
8. Santoro M, Carlomagno F, Romano A, et al. Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 1995;267:381-383.
9. Gimm O, Ukkat J, Niederle BE, et al. Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations are not affecting codon 634. World J Surg 2004;28:1312-1316.
10. Shannon KE, Gimm O, Hinze R, et al. Germline V804M mutation in the RET proto-oncogene in two apparently sporadic cases of FMTC presenting in the seventh decade of life. J Endocr Genet 1999;1:39-45.
11. Carlomagno F, Guida T, Anaganti S, et al. Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors. Oncogene 2004;23:6056-6063.
12. Lesueur F, Cebrian A, Cranston A, et al. Germline homozygous mutations at codon 804 in the RET proto-oncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients. J Clin Endocrinol Metab 2005;90:3454-3457.
13. Feldman GL, Edmonds MW, Ainsworth PJ, et al. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutation. Surgery 2000;128:93-98.
14. Lombardo F, Baudin E, Chiefari E, et al. Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804. J Clin Endocrinol Metab 2002;87:1674-1680.
15. Dralle H, Gimm O, Simon D, et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 1998;22:744-750.
16. Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003;349:1517-1525.